Anal cancer medical therapy

Jump to: navigation, search

Anal cancer Microchapters

Home

Patient Info

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes

Differentiating Anal cancer from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

MRI

CT

Ultrasound

Other Imaging studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anal cancer medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anal cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anal cancer medical therapy

CDC on Anal cancer medical therapy

Anal cancer medical therapy in the news

Blogs on Anal cancer medical therapy</small>

Directions to Hospitals Treating Anal cancer

Risk calculators and risk factors for Anal cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

The predominant therapy for anal cancer is chemotherapy and radiation.[1]

Medical therapy

Minimal invasive methods such as infrared coagulation is indicated for localized anal cancer.[2] Chemotherapy and radiation are the first-line therapy for metastatic disease.[3]

Localized anal cancer is treated with minimal invasive treatment as infrared coagulation.

Metastatic anal cancer is treated with chemotherapy (fluorouracil (5-FU) and cisplatin) concurrent with radiation.

References

  1. National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/anal/hp/anal-treatment-pdq#section/_36
  2. Goldstone, SE, Kawalek, AZ, Huyett, JW "Infrared Photocoagulator: A useful tool for treating anal squamous intraepithelial lesions". 2005. Diseases of the Colon & Rectum 58(5), 1042–1053.
  3. National Comprehensive Cancer Network.. NCCN Clinical Practice Guidelines in Oncology: Anal Carcinoma. V 1.2013.

Linked-in.jpg